[ET Net News Agency, 20 July 2026] INNOGEN-B (02591) rose 10.1% to HK$8.28.
It hits an intra-day high of HK$8.3, breaking above the 20-D SMA of HK$7.849, and an intra-day low of HK$7.53. The total shares traded was 2.04 million, with a value of HK$16.19m. The active buy/sell ratio is 66:34, with net buying turnover of HK$4.61m. BARCLAYS CAPITAL ASIA accounts for greatest net responsive buying turnover of HK$657,840, with volume weighted average price of HK$7.821. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$1.15m, with volume weighted average price of HK$7.838.
Basic Information| Nominal | 8.280 | % Chg | +10.11% |
| High | 8.300 | Low | 7.530 |
| Shares Tr | 2.04m | Turnover | 16.19m |
| 10-D SMA | 8.086 | %H.V | 96.195 |
| 20-D SMA | 7.849 | VWAP | 7.953 |
| 50-D SMA | 9.827 | RSI14 | 47.278 |
Status: Breaking above the 20-D SMA, active buy/sell ratio is 66:34, with net buying turnover of HK$4.61m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 8.28 | +10.11 |
| INNOVENT BIO (01801) | 92.70 | +4.22 |
| WUXI XDC (02268) | 56.20 | +5.44 |
| WUXI BIO (02269) | 38.14 | +3.14 |
| JOINN (06127) | 23.76 | Unchanged |
| BEONE MEDICINES (06160) | 191.30 | +3.07 |
| SKB BIO (06990) | 507.00 | +4.24 |
| DUALITYBIO-B (09606) | 241.20 | +12.19 |
| AKESO (09926) | 93.40 | +5.72 |
| REMEGEN (09995) | 83.10 | +8.98 |
(ed)
Nominal 
